ELANIX BIOTECHNOLOGIES AG Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN ... | https://www.dgap.de/dgap/News/adhoc/elanix-biotechnologies-nomina... |
Elanix Biotechnologies AG
WKN: A0WMJQ ISIN: DE000A0WMJQ4 Land: Deutschland
Nachricht vom 18.04.2019 | 09:30
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Elanix Biotechnologies AG / Key word(s): Personnel
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
18-Apr-2019 / 09:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
ELANIX BIOTECHNOLOGIES AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
Berlin, April 18 2019 - The Supervisory Board of Elanix Biotechnologies AG ("Company", "Elanix") has nominated by juridical order Professor Zhanfeng Cui and Anja Silling to become members of the Supervisory Board with immediate effect.
Today, the Supervisory Board of Elanix has nominated Anja Silling to become the Chairman of the Board and Fang Bao, an existing member of the board, to be the Vice Chairman.
Lee Ann Laurent-Applegate
CEO
18-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: | English | ||
Company: | Elanix Biotechnologies AG | ||
Stadthausbrücke 1-3 | |||
20355 Hamburg | |||
Phone: | Germany | 363 66 40 | |
+41 22 | |||
Fax: | +41 22 | 363 66 41 | |
E-mail: | info@elanix-bt.com | ||
Internet: | www.elanixbiotechnologies.com | ||
ISIN: | DE000A0WMJQ4 | ||
WKN: | A0WMJQ | ||
Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in | ||
Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange | |||
EQS News ID: 801589 | |||
End of Announcement | DGAP News Service | ||
DGAP - ein Service der EQS Group AG | |||
Twitter | Impressum | AGB | Rechtliche Hinweise & Datenschutz | |||
1 von 1 | 18.04.2019, 09:35 |
Attachments
- Original document
- Permalink
Disclaimer
Elanix Biotechnologies AG published this content on 18 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 18 April 2019 08:37:02 UTC
